Literature DB >> 13129527

Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria.

Ambrose O Talisuna1, Peter Langi, Theonest K Mutabingwa, Eric Van Marck, Niko Speybroeck, Thomas G Egwang, William W Watkins, Ian M Hastings, Umberto D'Alessandro.   

Abstract

The number of malaria parasite clones per infection-multiplicity of parasite clones-is affected by the transmission intensity, multiplicity increases with increasing transmission. This affects the frequency of parasites' sexual recombination and, if several mutations in different genes are involved, can break down drug resistant genotypes. Therefore, the effects of malaria transmission intensity on the spread of drug resistance could vary depending on the number of genes involved. Here we show that, compared to low transmission, intermediate-high transmission is associated with a 20-100-fold lower risk for the mutations linked to chloroquine resistance and a 6-17 times higher risk for those linked to sulphadoxine-pyrimethamine resistance. This is consistent with the hypothesis of a multigenic basis for chloroquine resistance and a monogenic basis for that of sulphadoxine-pyrimethamine. Reducing transmission intensity could slow the spread of resistance. However, a reduction below a critical threshold (e.g. when parasite prevalence in children 2-9 years old is around 60-80%) could, paradoxically, accelerate the spread of resistance to chloroquine and possibly to other drug combinations whose basis is multigenic. Our findings have important implications for malaria control because increasing drug resistance has a substantial impact on mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129527     DOI: 10.1016/s0020-7519(03)00156-5

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  19 in total

1.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

2.  Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study.

Authors:  Steve M Taylor; Alejandro Antonia; Gaoqian Feng; Victor Mwapasa; Ebbie Chaluluka; Malcolm Molyneux; Feiko O ter Kuile; Stephen J Rogerson; Steven R Meshnick
Journal:  Infect Genet Evol       Date:  2011-11-20       Impact factor: 3.342

3.  The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance.

Authors:  Eili Y Klein
Journal:  J Theor Biol       Date:  2013-09-25       Impact factor: 2.691

4.  Continuing intense malaria transmission in northern Uganda.

Authors:  Carla Proietti; Davide D Pettinato; Bernard N Kanoi; Edward Ntege; Andrea Crisanti; Eleanor M Riley; Thomas G Egwang; Chris Drakeley; Teun Bousema
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 5.  The global distribution and population at risk of malaria: past, present, and future.

Authors:  Simon I Hay; Carlos A Guerra; Andrew J Tatem; Abdisalan M Noor; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

6.  A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific.

Authors:  Cristian Koepfli; Lincoln Timinao; Tiago Antao; Alyssa E Barry; Peter Siba; Ivo Mueller; Ingrid Felger
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  Transmission intensity and drug resistance in malaria population dynamics: implications for climate change.

Authors:  Yael Artzy-Randrup; David Alonso; Mercedes Pascual
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

8.  Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya.

Authors:  Monica Shah; Simon Kariuki; Jodi Vanden Eng; Anna J Blackstock; Kimberly Garner; Wangeci Gatei; John E Gimnig; Kim Lindblade; Dianne Terlouw; Feiko ter Kuile; William A Hawley; Penelope Phillips-Howard; Bernard Nahlen; Edward Walker; Mary J Hamel; Laurence Slutsker; Ya Ping Shi
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

9.  Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005.

Authors:  Berenger Aristide Ako; André Toure Offianan; Marnie Johansson; Louis Koné Penali; Simon-Pierre Assanvo Nguetta; Carol Hopkin Sibley
Journal:  Infect Drug Resist       Date:  2012-08-01       Impact factor: 4.003

10.  Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago.

Authors:  Stanislas Rebaudet; Hervé Bogreau; Rahamatou Silaï; Jean François Lepere; Lionel Bertaux; Bruno Pradines; Jean Delmont; Philippe Gautret; Philippe Parola; Christophe Rogier
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.